• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, September 18, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

Blindness study shows how gene causes middle-age sight loss

Bioengineer by Bioengineer
September 6, 2017
in Biology
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Blindness study shows how gene causes middle-age sight loss.

Chemical changes in the eye that can lead to blindness have been identified by scientists, a conference has heard.

Their findings aid understanding of a genetic condition that causes sight loss for one in 3,000 people in the UK. It was presented at the Eye Development and Degeneration 2017 conference in Edinburgh on Tuesday.

Scientists examined how changes in a gene known as RPGR damage eye cells to cause a disorder known as X-linked retinitis pigmentosa. The condition is incurable and affects night and peripheral vision before gradually causing blindness in middle age.

Researchers led by the University of Edinburgh took skin samples from two patients and transformed stem cells – which can change into any cell type – into light-sensing eye cells known as photoreceptors. They compared these with cells from healthy relatives of the patients.

Photoreceptors – which decay in retinitis pigmentosa patients – differed in their fundamental structure when compared with those from family members.

Follow-up studies in mice identified key molecules that interact with RPGR to maintain the structure of photoreceptors. When RPGR is flawed, the structure is compromised and photoreceptors cannot function correctly, leading to sight loss.

Dr Roly Megaw from the University of Edinburgh's Medical Research Council Institute for Genetics and Molecular Medicine, who led the study, said: "By furthering our understanding of the RPGR gene and its effects on photoreceptor cells, we hope our findings bring us closer to developing a possible treatment for this devastating disease."

###

The study is published in the journal Nature Communications and was carried out at the University of Edinburgh's Medical Research Council Centre for Regenerative Medicine. It was funded by the Wellcome Trust and the charity Retinitis Pigmentosa Fighting Blindness.

Media Contact

Kate McAllister
[email protected]
44-131-650-6357
@edinunimedia

http://www.ed.ac.uk

http://www.ed.ac.uk/news/2017/gene-study-sheds-light-on-middle-age-sight-loss

Share12Tweet7Share2ShareShareShare1

Related Posts

Bacterial Resistance to Heavy Metals and Chromium Reduction

Bacterial Resistance to Heavy Metals and Chromium Reduction

September 18, 2025
Could Enhancing This Molecule Halt the Progression of Pancreatic Cancer?

Could Enhancing This Molecule Halt the Progression of Pancreatic Cancer?

September 17, 2025

3D Jaw Analysis Uncovers Omnivorous Diet of Early Bears

September 17, 2025

Wild Chimpanzees Consume the Equivalent of Several Alcoholic Drinks Daily, Study Finds

September 17, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    155 shares
    Share 62 Tweet 39
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    117 shares
    Share 47 Tweet 29
  • Physicists Develop Visible Time Crystal for the First Time

    67 shares
    Share 27 Tweet 17
  • Tailored Gene-Editing Technology Emerges as a Promising Treatment for Fatal Pediatric Diseases

    48 shares
    Share 19 Tweet 12

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Atlantic Reef Decline Boosts Sea-Level Rise

Revolutionary Light-Powered Motor Miniaturized to the Size of a Human Hair

Children’s Psychosocial Recovery Post-ICU Hospitalization Studied

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.